On November 11, 2024, the Indonesian Food and Drug Supervisory Agency (BPOM) released a draft Regulation No. 26 of 2025 concerning Risk Assessment of Ingredients Used in Natural Medicines, Health Supplements, Quasi-drugs, and Certain Cosmetic Products for public consultation. On October 3, 2025, BPOM officially issued and enforced the finalized version.

The regulation requires that ingredients used in certain dosage forms of natural medicines, health supplements, quasi-drugs, and cosmetics comply with the standards and quality requirements applicable to pharmaceutical ingredients. These “specific dosage forms” refer to products that, based on BPOM’s risk assessment, may pose potential health hazards if pharmaceutical-grade ingredients are not used.